相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ten years of human metapneumovirus research
F. Feuillet et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Human Metapneumovirus (HMPV) Binding and Infection Are Mediated by Interactions between the HMPV Fusion Protein and Heparan Sulfate
Andres Chang et al.
JOURNAL OF VIROLOGY (2012)
Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
David I. Bernstein et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006
Lauren J. Stockman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
Bart G. Jones et al.
VACCINE (2012)
A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice
Bosco A. Paes et al.
CANADIAN RESPIRATORY JOURNAL (2011)
Respiratory syncytial virus disease: update on treatment and prevention
Leonard R. Krilov
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
D. Wang et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
Paolo Durando et al.
HUMAN VACCINES (2011)
Local cytokine response upon respiratory syncytial virus infection
Susan M. Bueno et al.
IMMUNOLOGY LETTERS (2011)
Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins
Lori W. McGinnes et al.
JOURNAL OF VIROLOGY (2011)
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
Farnoosh Tayyari et al.
NATURE MEDICINE (2011)
A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease
Timothy F. Feltes et al.
PEDIATRIC RESEARCH (2011)
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
Kurt A. Swanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Progress in Respiratory Virus Vaccine Development
Alexander C. Schmidt
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
Akihito Sawada et al.
VACCINE (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Progress in the development of human parainfluenza virus vaccines
Alexander C. Schmidt et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2011)
Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model
Marie-Eve Hamelin et al.
ANTIVIRAL RESEARCH (2010)
Mode of action of adjuvants: Implications for vaccine safety and design
Béatris Mastelic et al.
BIOLOGICALS (2010)
Population-Based Incidence of Human Metapneumovirus Infection among Hospitalized Children
John V. Williams et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Assembly and Biological and Immunological Properties of Newcastle Disease Virus-Like Particles
Lori W. McGinnes et al.
JOURNAL OF VIROLOGY (2010)
Virologically Confirmed Population-based Burden of Hospitalization Caused by Respiratory Syncytial Virus, Adenovirus, and Parainfluenza Viruses in Children in Hong Kong
Susan S. Chiu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial
Xavier Carbonell-Estrany et al.
PEDIATRICS (2010)
Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non-RSV Bronchiolitis
Carla G. Garcia et al.
PEDIATRICS (2010)
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
Dirk Roymans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
Anne Schaap-Nutt et al.
VACCINE (2010)
Soluble recombinant human metapneumovirus G protein is immunogenic but not protective
Alex B. Ryder et al.
VACCINE (2010)
Structure of the Newcastle disease virus F protein in the post-fusion conformation
Kurt Swanson et al.
VIROLOGY (2010)
Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice
Yuanhui Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Hospitalization rates for human metapneumovirus infection among 0-to 3-year-olds in Gipuzkoa (Basque Country), Spain
G. Cilla et al.
EPIDEMIOLOGY AND INFECTION (2009)
Low-pH Triggering of Human Metapneumovirus Fusion: Essential Residues and Importance in Entry
Rachel M. Schowalter et al.
JOURNAL OF VIROLOGY (2009)
Bimolecular Complementation of Paramyxovirus Fusion and Hemagglutinin-Neuraminidase Proteins Enhances Fusion: Implications for the Mechanism of Fusion Triggering
Sarah A. Connolly et al.
JOURNAL OF VIROLOGY (2009)
Incubation periods of acute respiratory viral infections: a systematic review
Justin Lessler et al.
LANCET INFECTIOUS DISEASES (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN
Margarita Gomez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Integrin αvβ1 promotes infection by human metapneumovirus
Gabriella Cseke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
Bart Jones et al.
VACCINE (2009)
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
Joshua M. DiNapoli et al.
VACCINE (2009)
Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients
A. Safdar
BONE MARROW TRANSPLANTATION (2008)
Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling
S. Liao et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates
Emmalene J. Bartlett et al.
JOURNAL OF VIROLOGY (2008)
Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon
Sander Herfst et al.
JOURNAL OF VIROLOGY (2008)
Effectiveness of maternal influenza immunization in mothers and infants
K. Zaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
Roderick S. Tang et al.
VACCINE (2008)
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections
Xiaoyan Zhan et al.
VACCINE (2008)
Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques
Sander Herfst et al.
VACCINE (2008)
Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters
Jeanne H. Schickli et al.
VIROLOGY JOURNAL (2008)
Human metapneumovirus glycoprotein G inhibits innate immune responses
Xiaoyong Bao et al.
PLOS PATHOGENS (2008)
Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus
Celine Deffrasnes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B
Xiaoyan Zhan et al.
VACCINE (2007)
Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection
Rik L. de Swart et al.
VACCINE (2007)
Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus
Marie-Eve Hamelin et al.
JOURNAL OF GENERAL VIROLOGY (2007)
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines
Peter F. Wright et al.
VACCINE (2007)
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates
Sheila M. Nolan et al.
VACCINE (2007)
Attenuation and efficacy of human parainfluenza virus type I (HPIVI) vaccine candidates containing stabilized mutations in the P/C and L genes
Emmalene J. Bartlett et al.
VIROLOGY JOURNAL (2007)
Human metapneumovirus:: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged
Kevin C. Yim et al.
VACCINE (2007)
Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro
Stephane Biacchesi et al.
JOURNAL OF VIROLOGY (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A conserved region between the heptad repeats of paramyxovirus fusion proteins is critical for proper F protein folding
Amanda E. Gardner et al.
BIOCHEMISTRY (2007)
Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats
Gabriella Cseke et al.
JOURNAL OF VIROLOGY (2007)
Progress in respiratory virus vaccine development
Alexander C. Schmidt
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A potential molecular mechanism for hypersensitivity caused by formalin- inactivated vaccines
Amin Moghaddam et al.
NATURE MEDICINE (2006)
The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response
Alexander Kotelkin et al.
JOURNAL OF VIROLOGY (2006)
Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV 1) by reverse genetics generates attenuated and efficacious vaccine candidates
EJ Bartlett et al.
VACCINE (2006)
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity
MH Skiadopoulos et al.
VIROLOGY (2006)
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Function of small hydrophobic proteins of paramyxovirus
RL Wilson et al.
JOURNAL OF VIROLOGY (2006)
Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector
L Martinez-Sobrido et al.
JOURNAL OF VIROLOGY (2006)
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation
HS Yin et al.
NATURE (2006)
Addition of N-glycans in the stalk of the newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion
VR Melanson et al.
JOURNAL OF VIROLOGY (2006)
The structural basis of paramyxovirus invasion
Charles J. Russell et al.
TRENDS IN MICROBIOLOGY (2006)
Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo
QN Pham et al.
JOURNAL OF VIROLOGY (2005)
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates
A Bukreyev et al.
JOURNAL OF VIROLOGY (2005)
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates
S Biacchesi et al.
JOURNAL OF VIROLOGY (2005)
Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses
SM Nolan et al.
VACCINE (2005)
Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys
EJ Bartlett et al.
VACCINE (2005)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
RA Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy
DP Greenberg et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Reverse genetics of negative-stranded RNA viruses: A global perspective
P Walpita et al.
FEMS MICROBIOLOGY LETTERS (2005)
A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys
RS Tang et al.
VACCINE (2005)
Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages
KM Spann et al.
JOURNAL OF VIROLOGY (2004)
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old
RB Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Safety and immunogenicity of intranasal murine parainfluenza virus type I (Sendai virus) in healthy human adults
KS Slobod et al.
VACCINE (2004)
Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy
FR Laham et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys
RS Tang et al.
JOURNAL OF VIROLOGY (2004)
Revised indications for the use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the prevention of respiratory syncytial virus infections
JS Abramson et al.
PEDIATRICS (2003)
Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3′ proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity
RS Tang et al.
JOURNAL OF VIROLOGY (2003)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro
PR Wyde et al.
ANTIVIRAL RESEARCH (2003)
Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3
B Bossert et al.
JOURNAL OF VIROLOGY (2003)
Induction of apoptosis by paramyxovirus Simian virus 5 lacking a small hydrophobic gene
YA Lin et al.
JOURNAL OF VIROLOGY (2003)
Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infants
S Leader et al.
VALUE IN HEALTH (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
S Leader et al.
JOURNAL OF PEDIATRICS (2003)
Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion
T Takimoto et al.
JOURNAL OF VIROLOGY (2002)
Cleavage at the furin consensus sequence RAR/KR109 and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture
G Zimmer et al.
JOURNAL OF VIROLOGY (2002)
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone
AC Schmidt et al.
JOURNAL OF VIROLOGY (2002)
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo
MN Teng et al.
VIROLOGY (2001)
Immunopathogenesis of vaccine-enhanced RSV disease
PJM Openshaw et al.
VACCINE (2001)
Hemagglutinin-neuraminidase-independent fusion activity of simian virus 5 fusion (F) protein: Difference in conformation between fusogenic and nonfusogenic F proteins on the cell surface
M Tsurudome et al.
JOURNAL OF VIROLOGY (2001)
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants
MS Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
WG Nichols et al.
BLOOD (2001)
Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector
AA Haller et al.
JOURNAL OF VIROLOGY (2000)
Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: Response to ribavirin therapy
S Chakrabarti et al.
CLINICAL INFECTIOUS DISEASES (2000)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees
MN Teng et al.
JOURNAL OF VIROLOGY (2000)
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates
AC Schmidt et al.
JOURNAL OF VIROLOGY (2000)
Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines
MG Ottolini et al.
VIRAL IMMUNOLOGY (2000)
分享论文
